Search

everythinglearnresearchcommunity

for

Search:↓

Scalp microneedling may improve hair density and thickness for various alopecia types.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Hormonal therapies help treat female hair loss, but results are slow and vary.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

Recent advances in hair loss treatments show significant progress.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Higher androgen levels do not cause baldness in men.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Hydroxychloroquine may help treat alopecia areata in children.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

BTA safely and effectively treats hair loss, and works better with FNS.